Skip to main content

Peer Review reports

From: The efficacy and safety of specific therapies for cardiac Transthyretin-mediated amyloidosis: a systematic review and meta-analysis of randomized trials

Original Submission
22 Jan 2025 Submitted Original manuscript
26 Jan 2025 Author responded Author comments - Alonzo Armani Prata
27 Jan 2025 Author responded Author comments - Alonzo Armani Prata
Resubmission - Version 2
26 Jan 2025 Submitted Manuscript version 2
29 Jan 2025 Author responded Author comments - Alonzo Armani Prata
Resubmission - Version 3
29 Jan 2025 Submitted Manuscript version 3
2 Feb 2025 Author responded Author comments - Alonzo Armani Prata
Resubmission - Version 4
2 Feb 2025 Submitted Manuscript version 4
4 Feb 2025 Author responded Author comments - Alonzo Armani Prata
Resubmission - Version 5
4 Feb 2025 Submitted Manuscript version 5
7 Feb 2025 Reviewed Reviewer Report
9 Feb 2025 Reviewed Reviewer Report - Fuat Polat
11 Feb 2025 Reviewed Reviewer Report
11 Feb 2025 Reviewed Reviewer Report
28 Feb 2025 Author responded Author comments - Alonzo Armani Prata
Resubmission - Version 6
28 Feb 2025 Submitted Manuscript version 6
4 Mar 2025 Reviewed Reviewer Report - Fuat Polat
5 Mar 2025 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
11 Mar 2025 Editorially accepted
18 Apr 2025 Article published 10.1186/s12872-025-04653-4

You can find further information about peer review here.

Back to article page